ICD-11: Neurocognitive Disorders

被引:12
作者
Jessen, Frank [1 ]
Froelich, Lutz [2 ]
机构
[1] Univ Klinikum Koln, Klin & Poliklin Psychiat & Psychotherapie, Kerpener Str 62, D-50937 Cologne, Germany
[2] CIMH Geriatr Psychiat, Cologne, Germany
关键词
ICD-11; neurocognitive disorders; dementia; mild cognitive impairment; Alzheimer's disease; ALZHEIMERS ASSOCIATION WORKGROUPS; MILD COGNITIVE IMPAIRMENT; NATIONAL INSTITUTE; DIAGNOSTIC GUIDELINES; DISEASE; RECOMMENDATIONS; DEMENTIA; CRITERIA; VARIANT;
D O I
10.1055/s-0044-101607
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The section 06 (Mental, Behavioural or Neurodevelopmental Disorders) of the current version Beta Draft (Mortality and Morbidity Statistics, 16.12.2017) of the ICD 11 (International Statistical Classification of Diseases and Related Health Problems) replaces the F0-section of the ICD-10. Several changes, particularly with regard to the classification of neurodegenerative disorders have been introduced. It can be considered a progress that the concept of ''organic" syndromes has been dropped and that the section focusses on acquired conditions with cognition as the main area of symptoms. Regarding dementia, the 06 section still uses a syndromal approach of for example dementia due to Alzheimer disease (AD). The development of biomarkers and the molecular concept of AD is not incorporated, yet. In section 08 (Diseases of the Nervous System) Alzheimer disease without reference to symptoms can be classified, however, this section also misses reference to biomarkers, which leaves uncertainty of how the diagnosis should be made.
引用
收藏
页码:172 / 177
页数:6
相关论文
共 19 条
  • [1] The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
    Albert, Marilyn S.
    DeKosky, Steven T.
    Dickson, Dennis
    Dubois, Bruno
    Feldman, Howard H.
    Fox, Nick C.
    Gamst, Anthony
    Holtzman, David M.
    Jagust, William J.
    Petersen, Ronald C.
    Snyder, Peter J.
    Carrillo, Maria C.
    Thies, Bill
    Phelps, Creighton H.
    [J]. ALZHEIMERS & DEMENTIA, 2011, 7 (03) : 270 - 279
  • [2] Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010
    Beach, Thomas G.
    Monsell, Sarah E.
    Phillips, Leslie E.
    Kukull, Walter
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2012, 71 (04) : 266 - 273
  • [3] Posterior cortical atrophy
    Crutch, Sebastian J.
    Lehmann, Manja
    Schott, Jonathan M.
    Rabinovici, Gil D.
    Rossor, Martin N.
    Fox, Nick C.
    [J]. LANCET NEUROLOGY, 2012, 11 (02) : 170 - 178
  • [4] Drug development in Alzheimer's disease: the path to 2025
    Cummings, Jeffrey
    Aisen, Paul S.
    DuBois, Bruno
    Froelich, Lutz
    Jack, Clifford R., Jr.
    Jones, Roy W.
    Morris, John C.
    Raskin, Joel
    Dowsett, Sherie A.
    Scheltens, Philip
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2016, 8
  • [5] Deutsches Institut fur Medizinische Dokumentation und Information (DIMDI), 2017, ICD 10 GM VERS 2017
  • [6] Research criteria for the diagnosis of Alzheimer"s disease: revising the NINCDS-ADRDA criteria
    Dubois, Bruno
    Feldman, Howard H.
    Jacova, Claudia
    Dekosky, Steven T.
    Barberger-Gateau, Pascale
    Cummings, Jeffrey
    Delocourte, Andre
    Galasko, Douglas
    Gauthier, Serge
    Jicha, Gregory
    Meguro, Kenichi
    O'Brien, John
    Pasquier, Florence
    Robert, Philippe
    Rossor, Martin
    Solloway, Steven
    Stern, Yaakov
    Visser, Pieter J.
    Scheltens, Philip
    [J]. LANCET NEUROLOGY, 2007, 6 (08) : 734 - 746
  • [7] Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
    Dubois, Bruno
    Hampel, Harald
    Feldman, Howard H.
    Scheltens, Philip
    Aisen, Paul
    Andrieu, Sandrine
    Bakardjian, Hovagim
    Benali, Habib
    Bertram, Lars
    Blennow, Kaj
    Broich, Karl
    Cavedo, Enrica
    Crutch, Sebastian
    Dartigues, Jean-Francois
    Duyckaerts, Charles
    Epelbaum, Stephane
    Frisoni, Giovanni B.
    Gauthier, Serge
    Genthon, Remy
    Gouw, Alida A.
    Habert, Marie-Odile
    Holtzman, David M.
    Kivipelto, Miia
    Lista, Simone
    Molinuevo, Jose-Luis
    O'Bryant, Sid E.
    Rabinovici, Gil D.
    Rowe, Christopher
    Salloway, Stephen
    Schneider, Lon S.
    Sperling, Reisa
    Teichmann, Marc
    Carrillo, Maria C.
    Cummings, Jeffrey
    Jack, Cliff R., Jr.
    [J]. ALZHEIMERS & DEMENTIA, 2016, 12 (03) : 292 - 323
  • [8] Falkai P, 2013, DIAGNOSTISCHES STAT
  • [9] Grandal Leiros B, 2016, NEUROLOGIA
  • [10] Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
    McKeith, Ian G.
    Boeve, Bradley F.
    Dickson, Dennis W.
    Halliday, Glenda
    Taylor, John-Paul
    Weintraub, Daniel
    Aarsland, Dag
    Galvin, James
    Attems, Johannes
    Ballard, Clive G.
    Bayston, Ashley
    Beach, Thomas G.
    Blanc, Frederic
    Bohnen, Nicolaas
    Bonanni, Laura
    Bras, Jose
    Brundin, Patrik
    Burn, David
    Chen-Plotkin, Alice
    Duda, John E.
    El-Agnaf, Omar
    Feldman, Howard
    Ferman, Tanis J.
    Ffytche, Dominic
    Fujishiro, Hiroshige
    Galasko, Douglas
    Goldman, Jennifer G.
    Gomperts, Stephen N.
    Graff-Radford, Neill R.
    Honig, Lawrence S.
    Iranzo, Alex
    Kantarci, Kejal
    Kaufer, Daniel
    Kukull, Walter
    Lee, Virginia M. Y.
    Leverenz, James B.
    Lewis, Simon
    Lippa, Carol
    Lunde, Angela
    Masellis, Mario
    Masliah, Eliezer
    McLean, Pamela
    Mollenhauer, Brit
    Montine, Thomas J.
    Moreno, Emilio
    Mori, Etsuro
    Murray, Melissa
    O'Brien, John T.
    Orimo, Sotoshi
    Postuma, Ronald B.
    [J]. NEUROLOGY, 2017, 89 (01) : 88 - 100